Cellular localization of PD-L1 expression in mismatch-repair-deficient and proficient colorectal carcinomas.

Mod Pathol 2019 01 30;32(1):110-121. Epub 2018 Aug 30.

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Blockade of the interaction between PD-1 and its ligands PD-L1 has shown clinical efficacy across several tumor types, especially in mismatch-repair-deficient colorectal carcinoma. The aim of this study was to examine the pattern and cellular localization of PD-L1 expression in the different molecular subtypes of mismatch-repair-deficient colorectal cancers vs. their mismatch-repair-proficient counterparts. PD-L1/SATB2 double-antibody-immunohistochemistry was utilized to distinguish tumor cell from immune cell staining. We observed in our series of 129 colorectal adenocarcinomas that PD-L1 expression occurred primarily in tumor-associated-immune cells and most prominently at the tumor-stroma-interface of the invasive front. The level of invasive front immune cell staining was significantly higher in mismatch-repair-deficient tumors compared to mismatch-repair-proficient tumors (p < 0.001), but no difference was observed among the different subtypes of mismatch-repair-deficient tumors: Lynch syndrome-associated vs. MLH1-methylated vs. unexplained. While selected mismatch-repair-proficient tumors exhibited unusually high tumor-infiltrating-lymphocytes and had high level immune cell PD-L1 expression, a positive correlation between PD-L1 expression and high lymphocyte count was detected only in mismatch-repair-deficient tumors (r = 0.39, p < 0.001) and not in mismatch-repair-proficient tumors. Notably, true tumor cell PD-L1 expression in colorectal carcinoma was rare, present in only 3 of 129 tumors (2.3%): 2 MLH1-methylated and 1 mismatch-repair-proficient with high tumor-infiltrating-lymphocytes; and the staining in the tumor cells in all 3 was diffuse (>=50% of the tumor). These findings may serve to inform further efforts aiming to evaluate PD-L1 immunohistochemistry vis-à-vis molecular sub-classification as predictive biomarkers in the treatment of colorectal carcinoma.

Download full-text PDF

Source
http://www.nature.com/articles/s41379-018-0114-7
Publisher Site
http://dx.doi.org/10.1038/s41379-018-0114-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6309293PMC
January 2019
25 Reads

Publication Analysis

Top Keywords

pd-l1 expression
12
mismatch-repair-deficient colorectal
8
immune cell
8
localization pd-l1
8
cellular localization
8
invasive front
8
cell staining
8
utilized distinguish
4
distinguish tumor cell
4
staining observed
4
series 129
4
observed series
4
tumor cell immune
4
pd-l1/satb2 double-antibody-immunohistochemistry
4
molecular subtypes
4
expression molecular
4
pattern cellular
4
subtypes mismatch-repair-deficient
4
colorectal cancers
4
129 colorectal
4

References

(Supplied by CrossRef)

Similar Publications